- Report
- November 2020
- 101 Pages
Global
€21071EUR$22,000USD£17,944GBP
- Report
- June 2018
- 11 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 21 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 15 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 16 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 11 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 17 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Drug Pipelines
- October 2020
- 50 Pages
Global
From €3352EUR$3,500USD£2,855GBP
- Drug Pipelines
- August 2020
- 345 Pages
Global
From €1916EUR$2,000USD£1,631GBP
- Report
- June 2018
- 22 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 15 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 15 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 26 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 15 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- June 2018
- 12 Pages
Global
From €9578EUR$10,000USD£8,156GBP
- Report
- August 2022
- 243 Pages
Global
From €2394EUR$2,500USD£2,039GBP
- Report
- April 2022
- 330 Pages
Global
From €2394EUR$2,500USD£2,039GBP
- Report
- March 2022
Global
From €4645EUR$4,850USD£3,956GBP
- Report
- July 2019
- 340 Pages
Global
From €4166EUR$4,350USD£3,548GBP
From €718EUR$750USD£612GBP
The Lipoprotein market is a subset of the biotechnology industry that focuses on the development of drugs and treatments related to lipoproteins. Lipoproteins are molecules composed of proteins and lipids that are responsible for transporting cholesterol and other lipids throughout the body. Lipoproteins are essential for maintaining healthy cholesterol levels and are involved in many metabolic processes.
The Lipoprotein market is driven by the increasing prevalence of cardiovascular diseases, such as atherosclerosis, and the need for effective treatments. Additionally, the development of new technologies and the increasing availability of data are driving the growth of the Lipoprotein market.
Some of the major companies in the Lipoprotein market include Amgen, AstraZeneca, Merck, Pfizer, and Sanofi. These companies are involved in the development of drugs and treatments related to lipoproteins, as well as the research and development of new technologies. Show Less Read more